Related Experiment Videos
Death from massive hepatic necrosis in infectious mononucleosis
The New Zealand Medical Journal
|January 26, 1977
Abstract:
A case is reported of a 19-year-old youth who developed infectious mononucleosis and died 17 days after the onset of the illness. At autopsy massive hepatic necrosis was found, associated with enlargement of the liver.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an Australasian perspective.
Internal medicine journal·2015
Appropriateness of antineutrophil cytoplasmic antibody testing in a tertiary hospital.
Journal of clinical pathology·2009
Severe intimal hyperplasia with ischaemic colitis in two patients with hepatitis C.
Internal medicine journal·2007
HIV and tuberculosis co-infection in south-western Sydney: experience from a case series.
Internal medicine journal·2004
Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia.
The European respiratory journal·2002
Publicly funded healthcare, social insurance and justice in Aotearoa New Zealand.
The New Zealand medical journal·2026
Drilling a hole to shorten the gap: an Aotearoa New Zealand therapeutic algorithm for status epilepticus in NEUROPA (Madrid, Spain).
The New Zealand medical journal·2026
The impact of New Zealand's 2018 methamphetamine policy on residential contamination.
The New Zealand medical journal·2026
The Deterioration Early Warning System for aged residential care: a feasibility study with qualitative analysis.
The New Zealand medical journal·2026
Hand grip strength and future hospitalisations in Māori and non-Māori New Zealand octogenarians: the LiLACS NZ cohort study.
The New Zealand medical journal·2026
Phylogenetic inference with not-so-rare mutations and tiny organisms.
Systematic biology·2026
The 1820 Mallorca plague was not a classic bubonic outbreak.
Proceedings of the National Academy of Sciences of the United States of America·2026
Dose escalation for secondary loss of response in inflammatory bowel disease: 3-year outcomes and treatment persistence.
Internal medicine journal·2026